Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | -0.24% | 242.00 | 1.3% | $852.00m | |
| MRNA | Moderna, Inc. | -1.22% | 66.34 | 0.0% | $708.12m | |
| IMMU | Immunomedics, Inc. | 0.11% | 85.26 | 11.0% | $670.24m | |
| NVAX | Novavax, Inc. | 4.06% | 105.69 | 96.5% | $629.71m | |
| GILD | Gilead Sciences, Inc. | -1.43% | 62.19 | 1.0% | $564.97m | |
| ILMN | Illumina, Inc. | 2.25% | 279.15 | 3.5% | $461.22m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.89% | 560.14 | 2.7% | $434.70m | |
| BIIB | Biogen, Inc. | -0.22% | 271.59 | 1.6% | $336.71m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.90% | 261.45 | 1.9% | $319.01m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.69% | 113.21 | 2.0% | $280.91m | |
| SRNE | Sorrento Therapeutics, Inc. | -2.93% | 9.32 | 1.5% | $261.05m | |
| VXRT | Vaxart, Inc. | 1.11% | 7.27 | 0.0% | $206.71m | |
| MNTA | Momenta Pharmaceuticals, Inc. | 0.15% | 52.37 | 3.0% | $205.36m | |
| SGEN | Seattle Genetics, Inc. | -0.74% | 177.95 | 6.0% | $200.92m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -4.30% | 75.06 | 4.3% | $189.12m |
Company Profile
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the cell killing ability of radiation. The firm provides its service through Iomab-B, which is studied in the ongoing pivotal Phase 3 Study of Iomab-B in Elderly Relapsed or Refractory Acute Myeloid Leukemia (SIERRA) trial for BMT conditioning. The company was founded in 2002 and is headquartered in New York, NY.